Prostate cancer
Results
Phase 3
This trial was comparing intermittent hormone therapy with continuous hormone therapy for prostate cancer that had spread.
Recruitment start: 1 May 1995
Recruitment end: 1 September 2008
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Mr Peter Whelan
European Organisation for Research and Treatment of Cancer (EORTC)
National Institute for Health Research Cancer Research Network (NCRN)
Last reviewed: 21 Oct 2013
CRUK internal database number: 113